Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Dover Digest.
Press releases published on August 14, 2025
The Automotive Experience Alliance Advances Strategies to Align Elevate and Future-Proof Auto Shows
Year Two Initiatives Announced at Automotive Experience Alliance 2025 Annual Meeting WILMINGTON, DE, UNITED STATES, August 14, 2025 /EINPresswire.com/ -- The Automotive Experience Alliance (AEA), a coalition of auto shows with a shared interest in …
Navient declares third quarter common stock dividend
HERNDON, Va., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Navient (Nasdaq: NAVI) announced that its board of directors approved a 2025 third quarter dividend of $0.16 per share on the company's common stock. The third quarter 2025 dividend will be paid on Sept. 19, …
Inhibikase Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Activity
BOSTON and ATLANTA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases namely, …
Adtelligent Scoops “Best Overall OTT Solution Provider" at 2025 MarTech Breakthrough Awards
NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Adtelligent Inc., a global advertising technology company, has been recognized as the “Best Overall OTT Solution Provider” in the prestigious MarTech Breakthrough Awards 2025. This award highlights Adtelligent’s …
Onfolio Holdings Inc. Announces Second Quarter 2025 Financial Results and Provides Corporate Update
WILMINGTON, Del., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Onfolio Holdings Inc. (NASDAQ: ONFO, ONFOW) (OTC: ONFOP) ("Onfolio" or the "Company"), a company that acquires and manages a portfolio of digital marketing and online education businesses, announces …
The Brain Song Uses a Nasa-Inspired Gamma Wave Formula to Stimulate BDNF and Enhance Memory in 2025
New York, Aug. 14, 2025 (GLOBE NEWSWIRE) -- This release is for informational purposes only and has not been evaluated by the FDA. The Brain Song is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare …
Prelude Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
PRT7732, once daily oral SMARCA2 degrader, currently enrolling at the seventh dosing cohort (125 mg); Company to provide an update with preliminary clinical data, including PK/PD, safety and initial clinical activity by year end 2025 Phase 1 study of …